-
1
-
-
0000138089
-
Disorders of tetrahydrobiopterin and related biogenic amines
-
Scriver CR, Beaudet AL, Sly WS, Valle D, eds. New York, NY. McGraw-Hill
-
Blau N, Thöny B, Cotton RGH, Hyland K. Disorders of tetrahydrobiopterin and related biogenic amines. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Diseases. 8th ed. New York, NY. McGraw-Hill; 2001:1725-1776.
-
(2001)
The Metabolic and Molecular Bases of Inherited Diseases. 8th Ed.
, pp. 1725-1776
-
-
Blau, N.1
Thöny, B.2
Cotton, R.G.H.3
Hyland, K.4
-
2
-
-
0016913614
-
Hereditary progressive dystonia with marked diurnal fluctuation
-
Segawa M, Hosaka A, Miyagawa F, Nomura Y, Imai H. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol. 1976;14:215-233.
-
(1976)
Adv Neurol
, vol.14
, pp. 215-233
-
-
Segawa, M.1
Hosaka, A.2
Miyagawa, F.3
Nomura, Y.4
Imai, H.5
-
3
-
-
0033839129
-
Hereditary progressive dystonia with marked diurnal fluctuation
-
Segawa M. Hereditary progressive dystonia with marked diurnal fluctuation. Brain Dev. 2000;22:S65-S80.
-
(2000)
Brain Dev
, vol.22
-
-
Segawa, M.1
-
4
-
-
0000613043
-
Classification and investigation of dystonia
-
Marsden CD, Fahn S, eds. London, England: Butterworth-Heinemann
-
Fahn S, Marsden CD, Calne D. Classification and investigation of dystonia. In: Marsden CD, Fahn S, eds. Movement Disorders. London, England: Butterworth-Heinemann; 1987:332-358.
-
(1987)
Movement Disorders
, pp. 332-358
-
-
Fahn, S.1
Marsden, C.D.2
Calne, D.3
-
5
-
-
0031943362
-
Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia
-
Furukawa Y, Lang AE, Trugman JM, et al. Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia. Neurology. 1998;50:1015-1020.
-
(1998)
Neurology
, vol.50
, pp. 1015-1020
-
-
Furukawa, Y.1
Lang, A.E.2
Trugman, J.M.3
-
6
-
-
0031613968
-
Atypical presentations of dopa-responsive dystonia
-
Bandmann O, Marsden CD, Wood NW. Atypical presentations of dopa-responsive dystonia. Adv Neurol. 1998;78:283-290.
-
(1998)
Adv Neurol
, vol.78
, pp. 283-290
-
-
Bandmann, O.1
Marsden, C.D.2
Wood, N.W.3
-
7
-
-
0033060086
-
GTP cyclohydrolase deficiency: Intrafamilial variation in clinical phenotype, including levodopa responsiveness
-
Robinson R, McCarthy GT, Bandmann O, Dobbie M, Surtees R, Wood NW. GTP cyclohydrolase deficiency: intrafamilial variation in clinical phenotype, including levodopa responsiveness. J Neurol Neurosurg Psychiatry. 1999;66:86-89.
-
(1999)
J Neurol Neurosurg Psychiatry
, vol.66
, pp. 86-89
-
-
Robinson, R.1
McCarthy, G.T.2
Bandmann, O.3
Dobbie, M.4
Surtees, R.5
Wood, N.W.6
-
8
-
-
0342369398
-
Levodopa-responsive dystonia: GTP cyclohydrolase I or parkin mutations?
-
Tassin J, Dürr A, Bonnet AM, et al. Levodopa-responsive dystonia: GTP cyclohydrolase I or parkin mutations? Brain. 2000;123:1112-1121.
-
(2000)
Brain
, vol.123
, pp. 1112-1121
-
-
Tassin, J.1
Dürr, A.2
Bonnet, A.M.3
-
9
-
-
0035949789
-
Atypical presentation of dopa-responsive dystonia: Generalized hypotonia and proximal weakness
-
Kong C, Ko C, Tong SF, Lam C. Atypical presentation of dopa-responsive dystonia: generalized hypotonia and proximal weakness. Neurology. 2001;57:1121-1124.
-
(2001)
Neurology
, vol.57
, pp. 1121-1124
-
-
Kong, C.1
Ko, C.2
Tong, S.F.3
Lam, C.4
-
10
-
-
0031926568
-
Dystonia with motor delay in compound heterozygotes for GTP-cyclohydrolase I gene mutations
-
Furukawa Y, Kish SJ, Bebin EM, et al. Dystonia with motor delay in compound heterozygotes for GTP-cyclohydrolase I gene mutations. Ann Neurol. 1998;44:10-16.
-
(1998)
Ann Neurol
, vol.44
, pp. 10-16
-
-
Furukawa, Y.1
Kish, S.J.2
Bebin, E.M.3
-
11
-
-
0032847339
-
Dopa-responsive dystonia induced by a recessive GTP cyclohydrolase I mutation
-
Hwu WL, Wang PJ, Hsiao KJ, Wang TR, Chiou YW, Lee YM. Dopa-responsive dystonia induced by a recessive GTP cyclohydrolase I mutation. Hum Genet. 1999;105:226-230.
-
(1999)
Hum Genet
, vol.105
, pp. 226-230
-
-
Hwu, W.L.1
Wang, P.J.2
Hsiao, K.J.3
Wang, T.R.4
Chiou, Y.W.5
Lee, Y.M.6
-
13
-
-
0029829711
-
Mutant GTP cyclohydrolase I mRNA levels contribute to dopa-responsive dystonia onset
-
Hirano M, Tamaru Y, Ito H, Matsumoto S, Imai T, Ueno S. Mutant GTP cyclohydrolase I mRNA levels contribute to dopa-responsive dystonia onset. Ann Neurol. 1996;40:796-798.
-
(1996)
Ann Neurol
, vol.40
, pp. 796-798
-
-
Hirano, M.1
Tamaru, Y.2
Ito, H.3
Matsumoto, S.4
Imai, T.5
Ueno, S.6
-
14
-
-
0029162075
-
Exon skipping caused by a base substitution at a splice site in the GTP cyclohydrolase I gene in a Japanese family with hereditary progressive dystonia/dopa responsive dystonia
-
Hirano M, Tamaru Y, Nagai Y, Ito H, Imai T, Ueno S. Exon skipping caused by a base substitution at a splice site in the GTP cyclohydrolase I gene in a Japanese family with hereditary progressive dystonia/dopa responsive dystonia. Biochem Biophys Res Commun. 1995;213:645-651.
-
(1995)
Biochem Biophys Res Commun
, vol.213
, pp. 645-651
-
-
Hirano, M.1
Tamaru, Y.2
Nagai, Y.3
Ito, H.4
Imai, T.5
Ueno, S.6
-
15
-
-
0033525222
-
A novel missense mutant inactivates GTP cyclohydrolase I in dopa-responsive dystonia
-
Hirano M, Komure O, Ueno S. A novel missense mutant inactivates GTP cyclohydrolase I in dopa-responsive dystonia. Neurosci Lett. 1999;260:181-184.
-
(1999)
Neurosci Lett
, vol.260
, pp. 181-184
-
-
Hirano, M.1
Komure, O.2
Ueno, S.3
-
16
-
-
0025236440
-
Tetrahydrobiopterin biosynthetic activities in human macrophages, fibroblasts, THP-1, and T 24 cells: GTP-cyclohydrolase I is stimulated by interferon-γ and 6-pyruvoyl tetrahydropterin synthase and sepiapterin reductase are constitutively present
-
Werner ER, Werner-Felmayer G, Fuchs D, et al. Tetrahydrobiopterin biosynthetic activities in human macrophages, fibroblasts, THP-1, and T 24 cells: GTP-cyclohydrolase I is stimulated by interferon-γ and 6-pyruvoyl tetrahydropterin synthase and sepiapterin reductase are constitutively present. J Biol Chem. 1990;265:3189-3192.
-
(1990)
J Biol Chem
, vol.265
, pp. 3189-3192
-
-
Werner, E.R.1
Werner-Felmayer, G.2
Fuchs, D.3
-
17
-
-
0029066495
-
Regulation of GTP cyclohydrolase I gene expression and tetrahydrobiopterin content by nerve growth factor in cultures of superior cervical ganglia
-
Hirayama K, Kapatos G. Regulation of GTP cyclohydrolase I gene expression and tetrahydrobiopterin content by nerve growth factor in cultures of superior cervical ganglia. Neurochem Int. 1995;27:157-161.
-
(1995)
Neurochem Int
, vol.27
, pp. 157-161
-
-
Hirayama, K.1
Kapatos, G.2
-
18
-
-
0028291797
-
Regulation of tetrahydrobiopterin biosynthesis in cultured dopamine neurons by depolarization and cAMP
-
Zhu M, Hirayama K, Kapatos G. Regulation of tetrahydrobiopterin biosynthesis in cultured dopamine neurons by depolarization and cAMP. J Biol Chem. 1994;269:11825-11829.
-
(1994)
J Biol Chem
, vol.269
, pp. 11825-11829
-
-
Zhu, M.1
Hirayama, K.2
Kapatos, G.3
-
19
-
-
0034941330
-
Nerve growth factor signaling, neuroprotection, and neural repair
-
Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci. 2001;24:1217-1281.
-
(2001)
Annu Rev Neurosci
, vol.24
, pp. 1217-1281
-
-
Sofroniew, M.V.1
Howe, C.L.2
Mobley, W.C.3
-
21
-
-
0035798563
-
Catecholamines and serotonin are differently regulated by tetrahydrobiopterin: A study from 6-pyruvoyltetrahydropterin synthase knockout mice
-
Sumi-Ichinose S, Urano F, Kuroda R, et al. Catecholamines and serotonin are differently regulated by tetrahydrobiopterin: a study from 6-pyruvoyltetrahydropterin synthase knockout mice. J Biol Chem. 2001;276:41150-41160.
-
(2001)
J Biol Chem
, vol.276
, pp. 41150-41160
-
-
Sumi-Ichinose, S.1
Urano, F.2
Kuroda, R.3
-
22
-
-
0033595566
-
Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia
-
Furukawa Y, Nygaard TG, Gütlich M, et al. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Neurology. 1999;53:1032-1041.
-
(1999)
Neurology
, vol.53
, pp. 1032-1041
-
-
Furukawa, Y.1
Nygaard, T.G.2
Gütlich, M.3
-
23
-
-
13344282728
-
Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor
-
Rozmahel R, Wilschanski M, Matin A, et al. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet. 1996;12:280-287.
-
(1996)
Nat Genet
, vol.12
, pp. 280-287
-
-
Rozmahel, R.1
Wilschanski, M.2
Matin, A.3
-
24
-
-
0034723036
-
Polymorphisms in dopamine receptors: What do they tell us?
-
Wong AHC, Buckle CE, Van Tol HHM. Polymorphisms in dopamine receptors: what do they tell us? EurJ Pharmacol. 2000;410:183-203.
-
(2000)
EurJ Pharmacol
, vol.410
, pp. 183-203
-
-
Wong, A.H.C.1
Buckle, C.E.2
Van Tol, H.H.M.3
-
25
-
-
4243978485
-
Association of a missense change in the D2 dopamine receptor with myoclonus dystonia
-
Klein C, Brin MF, Kramer P, et al. Association of a missense change in the D2 dopamine receptor with myoclonus dystonia. Proc Natl Acad Sci U S A. 1999;96:5173-5176.
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 5173-5176
-
-
Klein, C.1
Brin, M.F.2
Kramer, P.3
-
26
-
-
0032739348
-
Dopamine D3 receptor gene polymorphism and responseto clozapine in schizophrenic Pakistani patients
-
Scharfetter J, Chaudhry HR, Hornik K, et al. Dopamine D3 receptor gene polymorphism and responseto clozapine in schizophrenic Pakistani patients. Eur Neuropsychopharmacol. 1999;10:17-20.
-
(1999)
Eur Neuropsychopharmacol
, vol.10
, pp. 17-20
-
-
Scharfetter, J.1
Chaudhry, H.R.2
Hornik, K.3
-
27
-
-
0032587535
-
Polymorphisms of the dopamine D4 receptor and response to antipsychotic drugs
-
Cohen BM, Ennulat DJ, Centorrino F, et al. Polymorphisms of the dopamine D4 receptor and response to antipsychotic drugs. Psychopharmacology. 1999;141:6-10.
-
(1999)
Psychopharmacology
, vol.141
, pp. 6-10
-
-
Cohen, B.M.1
Ennulat, D.J.2
Centorrino, F.3
-
28
-
-
0032926746
-
GTP cyclohydrolase I gene expression in the brains of male and female hph-1 mice
-
Shimoji M, Hirayama K, Hyland K, Kapatos G. GTP cyclohydrolase I gene expression in the brains of male and female hph-1 mice. J Neurochem. 1999;72:757-764.
-
(1999)
J Neurochem
, vol.72
, pp. 757-764
-
-
Shimoji, M.1
Hirayama, K.2
Hyland, K.3
Kapatos, G.4
-
29
-
-
0001136127
-
Estrogens, progesterone, and the extrapyramidal system
-
Bédard PJ, Langlier P, Dankova J, et al. Estrogens, progesterone, and the extrapyramidal system. Adv Neurol. 1979;24:411-422.
-
(1979)
Adv Neurol
, vol.24
, pp. 411-422
-
-
Bédard, P.J.1
Langlier, P.2
Dankova, J.3
-
30
-
-
0034952023
-
Clinical and molecular genetics of ADHD and Tourette syndrome: Two related and polygenic disorders
-
Comings DE. Clinical and molecular genetics of ADHD and Tourette syndrome: two related and polygenic disorders. Ann N YAcad Sci. 2001;931:50-83.
-
(2001)
Ann N YAcad Sci
, vol.931
, pp. 50-83
-
-
Comings, D.E.1
-
31
-
-
0034981705
-
Tourette syndrome: Clinical characteristics and current management strategies
-
Kosoff EH, Singer HS. Tourette syndrome: clinical characteristics and current management strategies. Paediatr Drugs. 2001;3:355-363.
-
(2001)
Paediatr Drugs
, vol.3
, pp. 355-363
-
-
Kosoff, E.H.1
Singer, H.S.2
-
32
-
-
0028991808
-
123I]-β-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder
-
123I]-β-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. Am J Psychiatry. 1995;152:1359-1361.
-
(1995)
Am J Psychiatry
, vol.152
, pp. 1359-1361
-
-
Malison, R.T.1
McDougle, C.J.2
Van Dyck, C.H.3
-
33
-
-
0029834998
-
Tourette syndrome: Prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding
-
Wolf SS, Jones DW, Knable MB, et al. Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science. 1996;273:1225-1227.
-
(1996)
Science
, vol.273
, pp. 1225-1227
-
-
Wolf, S.S.1
Jones, D.W.2
Knable, M.B.3
-
34
-
-
0034724154
-
Tourette's syndrome improvement with pergolide in a randomized, double-blind, cross-over trial
-
Gilbert DL, Sethuraman G, Sine L, Peters S, Sallee FR. Tourette's syndrome improvement with pergolide in a randomized, double-blind, cross-over trial. Neurology. 2000;54:1310-1315.
-
(2000)
Neurology
, vol.54
, pp. 1310-1315
-
-
Gilbert, D.L.1
Sethuraman, G.2
Sine, L.3
Peters, S.4
Sallee, F.R.5
-
35
-
-
0033693794
-
Responseto levodopa challenge in Tourette syndrome
-
Black KJ, Mink JW. Responseto levodopa challenge in Tourette syndrome. Mov Disord. 2000;15:1194-1198.
-
(2000)
Mov Disord
, vol.15
, pp. 1194-1198
-
-
Black, K.J.1
Mink, J.W.2
|